Robotic Surgery CO MEMIC agrees $1B valuation SPAC merger

13 August, 2021


Israel medical device company Memic Innovative Surgery Ltd. announced the signing of a definitive agreement for a SPAC merger with MedTech Acquisition Corporation (Nasdaq: MTAC). The merged company will have $360 million cash and an equity value of more than $1 billion.

Tadmor Levy & Co. acted as the Israeli counsel to Memic Innovative Surgery Ltd. in its agreement for a SPAC merger with MedTech Acquisition Corporation.

Memic was represented by Elie Sprung, Boaz Feinberg and Sapir Atal Davidovich.

Please read the full article at Globes.

Want to know more?
Contact us

Shiri Menache

Head of Marketing and Business Development

Matan Bar-Nir

Press Officer, OH! PR